57
Growth Score in past quarter
pts
Heat Score 57 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1247012
ZOMANEX is a drug manufacturing company specializing in transforming intravenous, injectable, and oral therapeutics products.
About the Company
Zomanex is a specialty pharmaceutical company dedicated to the development of proprietary pharmaceutical products based on its patented Orazom drug delivery platform. Orazom allows hydrophobic compounds to be efficiently absorbed in the small intestine, thereby permitting oral dosing of pharmaceutical compounds that have previously required iv or
injectable administration. Orazom 3907, the Company’s lead product opportunity, is an application of Orazom to Paclitaxel, an effective and off-patent cancer chemotherapeutic agent.